Peter R. Malone

Royal Berkshire Hospital

Papers

1

Total Citations

48

H-Index

1

About

Peter R. Malone is a leading figure in the application of mass spectrometry to cancer biomarker discovery, with a particular focus on prostate cancer. His seminal work, "MALDI mass spectrometry in prostate cancer biomarker discovery" (2013), has garnered 48 citations, establishing a foundational methodology for identifying protein and peptide signatures in biological fluids. Malone’s research bridges analytical chemistry and clinical oncology, developing high-throughput MALDI-TOF techniques that enable non-invasive, early-stage cancer detection. By refining sample preparation and data analysis protocols, he has improved the sensitivity and reproducibility of biomarker panels, directly impacting diagnostic workflows. His contributions extend beyond the lab, as he actively collaborates with urologists to translate these findings into clinical trials. Malone’s work is widely recognized for its rigor and translational potential, earning him invitations to speak at international proteomics conferences. For students and researchers, his research exemplifies how advanced mass spectrometry can unlock new avenues for personalized medicine, making him a pivotal figure in the quest for reliable cancer biomarkers.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
MALDI mass spectrometry in prostate cancer biomarker discovery
48 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Royal Berkshire Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago